| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |